Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.

Walsh SL, Middleton LS, Wong CJ, Nuzzo PA, Campbell CL, Rush CR, Lofwall MR.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):150-7. doi: 10.1016/j.drugalcdep.2012.10.024.

2.

A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence.

Somoza EC, Winship D, Gorodetzky CW, Lewis D, Ciraulo DA, Galloway GP, Segal SD, Sheehan M, Roache JD, Bickel WK, Jasinski D, Watson DW, Miller SR, Somoza P, Winhusen T.

JAMA Psychiatry. 2013 Jun;70(6):630-7. doi: 10.1001/jamapsychiatry.2013.872.

PMID:
23575810
3.

A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.

Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP.

Drug Alcohol Depend. 2015 Oct 1;155:105-10. doi: 10.1016/j.drugalcdep.2015.08.005.

4.

A randomized placebo-controlled trial of gabapentin for cocaine dependence.

Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV.

Drug Alcohol Depend. 2006 Feb 28;81(3):267-74.

PMID:
16169160
5.

Randomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit hyperactivity disorder.

Weisler RH, Pandina GJ, Daly EJ, Cooper K, Gassmann-Mayer C; 31001074-ATT2001 Study Investigators..

CNS Drugs. 2012 May 1;26(5):421-34. doi: 10.2165/11631990-000000000-00000.

PMID:
22519922
6.

Safety of atomoxetine in combination with intravenous cocaine in cocaine-experienced participants.

Cantilena L, Kahn R, Duncan CC, Li SH, Anderson A, Elkashef A.

J Addict Med. 2012 Dec;6(4):265-73. doi: 10.1097/ADM.0b013e31826b767f.

7.

Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.

Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W.

J Clin Psychiatry. 2003 Dec;64(12):1440-8.

PMID:
14728105
8.

Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.

Brodie JD, Case BG, Figueroa E, Dewey SL, Robinson JA, Wanderling JA, Laska EM.

Am J Psychiatry. 2009 Nov;166(11):1269-77. doi: 10.1176/appi.ajp.2009.08121811.

PMID:
19651710
9.

A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.

Winhusen T, Somoza E, Sarid-Segal O, Goldsmith RJ, Harrer JM, Coleman FS, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Afshar M, Ciraulo DA, Horn P, Montgomery MA, Elkashef A.

Drug Alcohol Depend. 2007 Dec 1;91(2-3):205-12.

PMID:
17628352
10.

Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.

BaldaƧara L, Cogo-Moreira H, Parreira BL, Diniz TA, Milhomem JJ, Fernandes CC, Lacerda AL.

J Clin Psychiatry. 2016 Mar;77(3):398-406. doi: 10.4088/JCP.14m09377.

PMID:
27046312
11.

Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J.

Drug Alcohol Depend. 2009 Apr 1;101(1-2):34-41. doi: 10.1016/j.drugalcdep.2008.10.016.

12.

A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.

Winhusen T, Somoza E, Ciraulo DA, Harrer JM, Goldsmith RJ, Grabowski J, Coleman FS, Mindrum G, Kahn R, Osman S, Mezinskis J, Li SH, Lewis D, Horn P, Montgomery MA, Elkashef A.

Drug Alcohol Depend. 2007 Dec 1;91(2-3):141-8.

PMID:
17629631
13.

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence.

Reid MS, Casadonte P, Baker S, Sanfilipo M, Braunstein D, Hitzemann R, Montgomery A, Majewska D, Robinson J, Rotrosen J.

Addiction. 2005 Mar;100 Suppl 1:43-57.

PMID:
15730349
14.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group..

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008.

PMID:
19716683
15.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
16.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007.

PMID:
24462581
17.

Topiramate for the treatment of cocaine addiction: a randomized clinical trial.

Johnson BA, Ait-Daoud N, Wang XQ, Penberthy JK, Javors MA, Seneviratne C, Liu L.

JAMA Psychiatry. 2013 Dec;70(12):1338-46. doi: 10.1001/jamapsychiatry.2013.2295.

PMID:
24132249
18.

A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients.

Raby WN, Rubin EA, Garawi F, Cheng W, Mason E, Sanfilippo L, Lord S, Bisaga A, Aharonovich E, Levin F, McDowell D, Nunes EV.

Am J Addict. 2014 Jan-Feb;23(1):68-75. doi: 10.1111/j.1521-0391.2013.12065.x.

19.

Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.

Montoya ID, Gorelick DA, Preston KL, Schroeder JR, Umbricht A, Cheskin LJ, Lange WR, Contoreggi C, Johnson RE, Fudala PJ.

Clin Pharmacol Ther. 2004 Jan;75(1):34-48.

20.

A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

Kampman KM, Dackis C, Pettinati HM, Lynch KG, Sparkman T, O'Brien CP.

Addict Behav. 2011 Mar;36(3):217-21. doi: 10.1016/j.addbeh.2010.11.003.

Supplemental Content

Support Center